Welcome to the D. H. Taylor Analysis Forum. This is for the stock market & stock options analysis, tech stocks analysis, & cannabis stocks analysis forum & discussion.
Feel free to find your favorite stocks and contribute content as you please; content that continues the discussion of, and analysis of, stocks. – D. H. Taylor
Revenue of $320.3 million, up 49% year over year and 1% sequentially -- Retail revenue grew 3% sequentially across industry leading U.S. network of 168 dispensaries as of June 30, 2022 -- GAAP gross margin of 57% and Adjusted EBITDA* margin of 35%
TALLAHASSEE, Fla., Aug. 10, 2022 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended June 30, 2022. Results are reported in U.S. dollars unless otherwise indicated.
Q2 2022 Financial Highlights*
-- Revenue increased 49% year over year to $320.3 million from $215.1 million and 1% sequentially. -- Retail revenue increased 3% to $298.6 million and wholesale, licensing and other revenue declined by 22% sequentially to $21.7 million. -- Gross profit of $182.2 million and GAAP gross margin of 57% in the second quarter compared to gross profit of $178.2 million and GAAP gross margin of 56% in the first quarter of 2022. -- Net loss of $22.5 million, a sequential improvement of 30%. Adjusted net loss of $1.1 million* excludes $11.8 million of transaction, acquisition, integration, and other non-recurring charges primarily associated with the Harvest acquisition, a $5.2 million earnout payment for acquired cultivation in Arizona, $4.3 million in asset impairments associated with the closing of redundant cultivation facilities in Florida and a loss of $0.7 million due to the repurposing of a development stage production site in Arizona. -- Adjusted EBITDA grew 17% year over year to $111.0 million*, or 35% of revenue in the second quarter compared to Adjusted EBITDA of $105.5 million*, or 33% of revenue in the first quarter of 2022. -- Cash at quarter end of $181.4 million. *See "Non-GAAP Financial Measures" below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.
Q2 2022 Operational Highlights
-- Opened 6 new dispensaries in Fort Myers and Zephyrhills, Florida; Framingham, Massachusetts; Coatesville, Pennsylvania; and Parkersburg and South Charleston, West Virginia. Relocated one dispensary in New Port Richey, Florida. -- Exited the second quarter with operations in 11 states, with 32% of our retail locations outside of the state of Florida. -- Produced over 10 million finished goods units in the second quarter, up 79% year over year. -- Received Notice of Award of Provisional Dispensary License for District Southeast-3 in Columbus, Ohio. -- Successfully launched Modern FlowerTM, MuseTM, Roll OneTM, and Sweet TalkTM branded products across markets including Arizona, Florida, Maryland, Pennsylvania and West Virginia. -- Hosted inaugural Analyst Day event featuring production facility tours including a new 750 thousand square foot automated cultivation facility and corporate presentation showcasing production, retail, branding and marketing, and data analytics capabilities. -- Expanded roll out and applications of Customer Data Platform for targeted marketing campaigns.
Recent Events
-- Celebrated six year anniversary of first retail sale in Florida. -- Opened 7 new dispensaries in Phoenix, Arizona; Apopka, Coral Springs, Hollywood, and Kissimmee, Florida; and Hurricane and Morgantown, West Virginia. -- New Phoenix dispensary represented first branded Trulieve store in Arizona, kicking off statewide rebranding efforts to continue over the next year. -- Currently operate 175 retail dispensaries and over 4.0 million square feet of cultivation and processing capacity in the United States. -- Elected to discontinue wholesale operations in Nevada and are currently evaluating options to exit the market. -- Made an initial contribution to the Smart and Safe Florida campaign, which aims to legalize adult use marijuana in Florida through a ballot initiative in November 2024.
Management Commentary
"Our team delivered strong second quarter results with topline growth and margin improvement by staying focused on our plan," said Kim Rivers, Trulieve CEO. "During our mid-year strategic review, we identified proactive measures to address the rapidly evolving economic landscape."
Rivers continued, "We are committed to meeting customer needs, improving performance in core markets, managing cash wisely, and streamlining operations across the company. We strongly believe that taking firm and decisive action now will better position the organization to capitalize on numerous catalysts in the years ahead. Trulieve has the capital, discipline, and experience to navigate short term headwinds and emerge as a stronger company."
Financial Guidance
Factoring in strategic changes across our business, the impact of inflation on consumer spending, softness in wholesale markets, and the lack of visibility in the current macroeconomic environment, we are adjusting 2022 revenue guidance by 5% from the low end of our prior outlook to $1.25 billion to $1.3 billion. Accordingly, we anticipate Adjusted EBITDA will be in the range of $415 million to $450 million.
Financial Highlights
For the Six Months Results of Operations For the Three Months Ended Ended --------------------- ---------------------------------------- ----------------------- (Figures in millions June June March June June and % change based on 30, 30, 31, 30, 30, these figures) 2022 2021 change 2022 change 2022 2021 change --------------------- ------- ------ ------ ------- ------ ------- ------ ------ Revenue $320.3 $215.1 49 % $318.3 1 % $638.6 $408.9 56 % Gross Profit $182.2 $144.5 26 % $178.2 2 % $360.3 $279.7 29 % Gross Margin % 57 % 67 % 56 % 56 % 68 % Adjusted Gross Profit $183.4 $146.7 25 % $185.4 -1 % $368.8 $285.7 29 % Adjusted Gross Margin % 57 % 68 % 58 % 58 % 70 % Operating Expenses $144.2 $68.2 111 % $149.5 -4 % $293.7 $130.9 124 % Operating Expenses % 45 % 32 % 47 % 46 % 32 % Net Income (Loss) $(22.5) $40.9 --- $(32.0) --- $(54.5) $71.0 --- Adjusted Net Income (Loss) $(1.1) $47.0 --- $ 1.7 --- $ 0.6 $85.5 --- Diluted Shares Outstanding 187.2 133.0 187.1 187.1 127.9 EPS $(0.12) $0.31 --- $(0.17) --- $(0.29) $0.55 --- Adjusted EPS $(0.01) $0.35 --- $ 0.01 --- $ 0.00 $0.67 --- Adjusted EBITDA $111.0 $94.9 17 % $105.5 5 % $216.5 $185.7 17 % Adjusted EBITDA Margin % 35 % 44 % 33 % 34 % 45 % --------------------- ------ ----- ------ ------ ------ ------ ----- ------
Conference Call
The Company will host a conference call and live audio webcast on August 10, 2022, at 8:30 A.M. Eastern time, to discuss its second quarter 2022 financial results.
Interested parties can join the conference call by dialing in as directed below. Please dial in 15 minutes prior to the call.
North American toll free: 1-888-317-6003 passcode: 6100603
International: 1-412-317-6061 passcode: 6100603
A live audio webcast of the conference call will be available at:
https://app.webinar.net/eNPDleGz6oj
A powerpoint presentation is available at
https://investors.trulieve.com/events-presentations
An archived replay of the webcast will be available at:
https://investors.trulieve.com/events-presentations
The Company's Form 10-Q for the quarter ended June 30, 2022, will be available on the SEC's website or at https://investors.trulieve.com/financial-information/quarterly-results. The Company's Management Discussion and Analysis for the period and the accompanying financial statements and notes will be available under the Company's profile on SEDAR and on its website at https://investors.trulieve.com/financial-information/quarterly-results. This news release is not in any way a substitute for reading those financial statements, including the notes to the financial statements.
Non-GAAP Financial Measures
In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP financial measures, including adjusted gross profit, adjusted net income, adjusted net income per diluted share, and adjusted cash flow from operations. Our management uses these non-GAAP financial measures in conjunction with GAAP financial measures to evaluate our operating results and financial performance. We believe these measures are useful to investors as they are widely used measures of performance and can facilitate comparison to other companies. These non-GAAP financial measures have limitations as analytical tools in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Because of these limitations, these non-GAAP financial measures should be considered along with GAAP financial performance measures. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly
I Don't understand why the MSO's are Green and Trulieve almost 3% down this AM you would think it would be up more than the rest of the MSO's
Adjusted EBITDA of 35%.... the main stock market is about 22.5%. Trulieve will be a true leader in this space.
D. H. Taylor
A live audio webcast of the conference call will be available at:
https://app.webinar.net/eNPDleGz6oj
Trulieve pulls out of Nevada and some California locations, adds to other locations and Arizona
@jeffspahn2011gmail-com GTBIF is starting to head upward. TCNNF is flat after its earnings miss and revenue miss. But, they are likely to get there.
D. H. Taylor
@jeffspahn2011gmail-com GTBIF is starting to head upward. TCNNF is flat after its earnings miss and revenue miss. But, they are likely to get there.
D. H. Taylor